Pharmalittle: We’re reading about a Hims Super Bowl ad, USAID freeze hurting clinical trial patients, and more
Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs afoul of pharmaceutical advertising rules
Related Articles
Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer – Alan Bryce
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
Researchers ‘stunned’ after HHMI abruptly cancels program to make science more inclusive
The Howard Hughes Medical Institute abruptly ended a $60 million program to improve the retention of diverse college students
Pharmalittle: We’re reading about a Hims Super Bowl ad, USAID freeze hurting clinical trial patients, and more
Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs afoul of pharmaceutical advertising rules
Lilly expands GLP-1 research to hypertension, neuro conditions
Morning. Today, we have a look at the White House’s reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding…
An Overview of Strategies and Therapeutic Advances in Metastatic Prostate Cancer – Rana McKay
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
Signs of life at the CDC
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I keep a slim copy
Dr David Dunstan – Physical Activity | Sedentary Behaviour | Diabetes | Physical Activity Researcher
In this episode, we have Professor David Dunstan from the Baker Heart and Diabetes Institute in Melbourne. His research focuses on the role of physical…
Advancements in Lutetium-PSMA Therapy for Prostate Cancer: Clinical Trials and Future Directions – Ken Herrmann
Oliver Sartor and Ken Herrmann discuss the current state and future directions of PSMA ligand therapy in prostate cancer treatment. Dr. Herrmann presents recent findings…
Lawmakers ask FDA to review Hims’ Super Bowl ad for ‘misleading’ patients
Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight loss drugs.
Q&A: New York’s plan for boosting life expectancy, neighborhood by neighborhood
Life expectancy in New York City has been falling. A new plan to address it includes basic income, prescribing parks, and community health workers.